Neutral lipid storage disease with myopathy and dropped head syndrome. Report of a new variant susceptible of treatment with late diagnosis

•We report a novel missense variant in PNPLA2 in a patient with NLSDM.•Heterozygotes individuals for mutations in PNPLA2 may have mild clinical manifestations.•NLSDM is susceptible to pharmacological management.•This case highlights the importance of considering genetic diseases in conditions withou...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical neuroscience Vol. 58; pp. 207 - 209
Main Authors Garcia, Mary A., Rojas, Jorge A., Millán, Sonia P., Flórez, Adriana A.
Format Journal Article
LanguageEnglish
Published Scotland Elsevier Ltd 01.12.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:•We report a novel missense variant in PNPLA2 in a patient with NLSDM.•Heterozygotes individuals for mutations in PNPLA2 may have mild clinical manifestations.•NLSDM is susceptible to pharmacological management.•This case highlights the importance of considering genetic diseases in conditions without usual clinical course. Neutral lipid storage disease with myopathy (NLSDM) is characterized by the accumulation of cytoplasmic triglyceride droplets in various tissues; this very rare condition is caused by mutations in the PNPLA2 gene, susceptible to specific pharmacological management that decreases clinical progression. We describe the clinical and biochemical characteristics of a Colombian patient with a previously unreported homozygous mutation in the PNPLA2 gene with a difficult to manage disease, who was diagnosed late by advances in molecular techniques.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0967-5868
1532-2653
DOI:10.1016/j.jocn.2018.10.046